SCHEMBL2581930

SCHEMBL2581930

CC(C)(C)OC(=O)N1Cc2cc(C3(Cl)CCC(c4cccnc4F)CC3)ccc2-n2cnnc2C1

nearest known ligand 0.38

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
OXTR P30559 3/20 0.34
AVPR1A P37288 3/20 0.34
FNTA P49354 6/20 0.33
FNTB P49356 6/20 0.33
DDB1 Q16531 2/20 0.33
CRBN Q96SW2 2/20 0.33
AVPR2 P30518 3/20 0.33
KCNH2 Q12809 2/20 0.33
POLB P06746 1/20 0.32
LMNA P02545 1/20 0.32
GPR119 Q8TDV5 1/20 0.32
IDH1 O75874 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2577034 0.93 POLB (0.38) OXTRAVPR1AFNTAFNTBDDB1
SCHEMBL2577744 0.91 OXTR (0.35) OXTRAVPR1AFNTAFNTBDDB1
SCHEMBL2579657 0.90 OXTR (0.36) OXTRAVPR1AFNTAFNTBDDB1
SCHEMBL2565485 0.89 FNTA (0.37) OXTRAVPR1AFNTAFNTBDDB1
SCHEMBL2565904 0.88 AVPR2 (0.37) OXTRAVPR1ADDB1CRBNAVPR2
SCHEMBL2550063 0.87 NAMPT (0.40) OXTRAVPR1ADDB1CRBNAVPR2
SCHEMBL2556747 0.87 HDAC1 (0.38) OXTRAVPR1ADDB1CRBNGPR119
SCHEMBL2586133 0.86 AVPR1A (0.33) OXTRAVPR1AFNTAFNTBDDB1
SCHEMBL2469674 0.86 PDE4A (0.34) OXTRAVPR1AFNTAFNTBDDB1
SCHEMBL2548383 0.85 MAPT (0.37) OXTRAVPR1ADDB1CRBNAVPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2560975-A1 HETEROARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES AS VASOPRESSIN V1A RECEPTOR ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2013-02-27 EP disclosed
WO-2011131596-A1 HETEROARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES AS VASOPRESSIN V1A RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2011-10-27 WO disclosed